LFMD LIFEMD INC

LifeMD to Participate in the BTIG Digital Health Forum

LifeMD to Participate in the BTIG Digital Health Forum

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital Health Forum on November 24, 2025. Management will participate in a virtual panel discussion titled “Creating a Scalable Virtual Primary Care and Obesity Health Platform” at 4:00 p.m. Eastern time and will be available for one-on-one virtual meetings.

Investors can register for the conference by contacting their BTIG representative.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit .

Investor Contact

Marc Benathen, Chief Financial Officer

Media Contact

Jessica Friedeman, Chief Marketing and Product Officer



EN
10/11/2025

Underlying

LFMDLIFEMD INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscri...

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD’s collaboration with Novo Nordisk NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the launch of Novo Nordisk's new Wegovy® (semaglutide) subscription program — the first and only GLP-1 subscription offering of its kind — now available through LifeMD. The program meaningfully expands patient access to branded GLP-1 therapy and suppo...

19h / 17m 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2026, to holders of record at the close of business on April 3, 2026. About LifeMD, Inc.LifeMD® is a leading provider of virtual primary care....

March 24, 2026 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financia...

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Atul Kavthekar as Chief Financial Officer, effective today. The Company also announced leadership changes to support its next phase of growth. Marc Benathen, the Company’s current CFO, is departing to pursue a new opportunity and will remain with LifeMD through March 31, 2026, to facilitate a smooth transition. “We are thrilled to wel...

March 16, 2026 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LifeMD Reports Fourth Quarter and Full Year 2025 Results Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.Benefits infrastructure on track to cover approximately 220 million America...

March 9, 2026 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD to Participate in Two Investor Conferences During March

LifeMD to Participate in Two Investor Conferences During March NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March: Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. ...

March 3, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch